SEARCH

SEARCH BY CITATION

References

  • Angèle S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gérard JP, Hall J. 2003. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63:87178725.
  • Atencio DP, Iannuzzi CM, Green S, Stock RG, Bernstein JL, Rosenstein BS. 2001. Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high-performance liquid chromatography. Environ Mol Mutagen 38:200208.
  • Broeks A, Braaf LM, Huseinovic A, Schmidt MK, Russell NS, van Leeuwen FE, Hogervorst FB, Van 't Veer LJ. 2008. The spectrum of ATM missense variants and their contribution to contralateral breast cancer. Breast Cancer Res Treat 107:243248.
  • Brunet J, Gutierrez-Enriquez S, Torres A, Berez V, Sanjose S, Galceran J, Izquierdo A, Menendez JA, Guma J, Borras J. 2008. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations. Clin Genet 73:465473.
  • Buchholz TA, Weil MM, Ashorn CL, Strom EA, Sigurdson A, Bondy M, Chakraborty R, Cox JD, McNeese MD, Story MD. 2004. A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls. Cancer 100:13451351.
  • Chou LS, Lyon E, Wittwer CT. 2005. A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model. Am J Clin Pathol 124:330338.
  • De Leeneer K, Coene I, Poppe B, De Paepe A, Claes K. 2008. Rapid and sensitive detection of BRCA1/2 mutations in a diagnostic setting: comparison of two high-resolution melting platforms. Clin Chem 54:982989.
  • Dörk T, Bendix R, Bremer M, Rades D, Klöpper K, Nicke M, Skawran B, Hector A, Yamini P, Steinmann D, Weise S, Stuhrmann M, Karstens JH. 2001. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res 61:76087615.
  • Garritano S, Gemignani F, Voegele C, Nguyen-Dumont T, Le Calvez-Kelm F, De Silva D, Lesueur F, Landi S, Tavtigian SV. 2009. Determining the effectiveness of high resolution melting analysis for SNP genotyping and mutation scanning at the TP53 locus. BMC Genetics 10:5 PMID: 19222838 [PubMed-in process].
  • Gonzalez-Hormazabal P, Bravo T, Blanco R, Valenzuela CY, Gomez F, Waugh E, Peralta O, Ortuzar W, Reyes JM, Jara L. 2008. Association of common ATM variants with familial breast cancer in a South American population. BMC Cancer 8:117.
  • Graham R, Liew M, Meadows C, Lyon E, Wittwer CT. 2005. Distinguishing different DNA heterozygotes by high-resolution melting. Clin Chem 51:12951298.
  • Izatt L, Greenman J, Hodgson S, Ellis D, Watts S, Scott G, Jacobs C, Liebmann R, Zvelebil MJ, Mathew C, Solomon E. 1999. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer. Genes Chromosomes Cancer 26:286294.
  • Liew M, Pryor R, Palais R, Meadows C, Erali M, Lyon E, Wittwer C. 2004. Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin Chem 50:11561164.
  • Livingston RJ, von Niederhausern A, Jegga AG, Crawford DC, Carlson CS, Rieder MJ, Gowrisankar S, Aronow BJ, Weiss RB, Nickerson DA. 2004. Pattern of sequence variation across 213 environmental response genes. Genome Res 14:18211831.
  • Maillet P, Bonnefoi H, Vaudan-Vutskits G, Pajk B, Cufer T, Foulkes WD, Chappuis PO, Sappino AP. 2002. Constitutional alterations of the ATM gene in early onset sporadic breast cancer. J Med Genet 39:751753.
  • Montgomery J, Wittwer CT, Palais R, Zhou L. 2007. Simultaneous mutation scanning and genotyping by high-resolution DNA melting analysis. Nat Protoc 2:5966.
  • Reed GH, Wittwer CT. 2004. Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. Clin Chem 50:17481754.
  • Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D, Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR, Rahman N. 2006. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38:873875.
  • Seipp MT, Durtschi JD, Liew MA, Williams J, Damjanovich K, Pont-Kingdon G, Lyon E, Voelkerding KV, Wittwer CT. 2007. Unlabeled oligonucleotides as internal temperature controls for genotyping by amplicon melting. J Mol Diagn 9:284289.
  • Sevilla C, Moatti JP, Julian-Reynier C, Eisinger F, Stoppa-Lyonnet D, Bressac-de Paillerets B, Sobol H. 2002. Testing for BRCA1 mutations: a cost-effectiveness analysis. Eur J Hum Genet 10:599606.
  • Sommer SS, Jiang Z, Feng J, Buzin CH, Zheng J, Longmate J, Jung M, Moulds J, Dritschilo A. 2003. ATM missense mutations are frequent in patients with breast cancer. Cancer Genet Cytogenet 145:115120.
  • Takano EA, Mitchell G, Fox SB, Dobrovic A. 2008. Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis. BMC Cancer 8:59.
  • Teraoka SN, Malone KE, Doody DR, Suter NM, Ostrander EA, Daling JR, Concannon P. 2001. Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer 92:479487.
  • Thorstenson YR, Shen P, Tusher VG, Wayne TL, Davis RW, Chu G, Oefner PJ. 2001. Global analysis of ATM polymorphism reveals significant functional constraint. Am J Hum Genet 69:396412.
  • Zhou L, Myers AN, Vandersteen JG, Wang L, Wittwer CT. 2004. Closed-tube genotyping with unlabeled oligonucleotide probes and a saturating DNA dye. Clin Chem 50:13281335.
  • Zhou L, Wang L, Palais R, Pryor R, Wittwer CT. 2005. High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution. Clin Chem 51:17701777.